- Home
- LKCO vs SCNI Comparison
LKCO vs SCNI Comparison
Compare LKCO & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LKCO
- SCNI
- Stock Information
- Founded
- LKCO 2009
- SCNI 2003
- Country
- LKCO China
- SCNI Israel
- Employees
- LKCO N/A
- SCNI N/A
- Industry
- LKCO EDP Services
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LKCO Technology
- SCNI Health Care
- Exchange
- LKCO Nasdaq
- SCNI Nasdaq
- Market Cap
- LKCO 4.3M
- SCNI 3.5M
- IPO Year
- LKCO N/A
- SCNI N/A
- Fundamental
- Price
- LKCO $1.45
- SCNI $3.35
- Analyst Decision
- LKCO
- SCNI
- Analyst Count
- LKCO 0
- SCNI 0
- Target Price
- LKCO N/A
- SCNI N/A
- AVG Volume (30 Days)
- LKCO 16.3K
- SCNI 9.7K
- Earning Date
- LKCO 01-07-2025
- SCNI 11-22-2024
- Dividend Yield
- LKCO N/A
- SCNI N/A
- EPS Growth
- LKCO N/A
- SCNI N/A
- EPS
- LKCO N/A
- SCNI 8.20
- Revenue
- LKCO $10,236,235.00
- SCNI $452,000.00
- Revenue This Year
- LKCO N/A
- SCNI N/A
- Revenue Next Year
- LKCO N/A
- SCNI N/A
- P/E Ratio
- LKCO N/A
- SCNI $0.41
- Revenue Growth
- LKCO N/A
- SCNI N/A
- 52 Week Low
- LKCO $1.43
- SCNI $2.23
- 52 Week High
- LKCO $8.00
- SCNI $8.92
- Technical
- Relative Strength Index (RSI)
- LKCO 38.38
- SCNI 48.93
- Support Level
- LKCO $1.46
- SCNI $3.30
- Resistance Level
- LKCO $1.75
- SCNI $3.50
- Average True Range (ATR)
- LKCO 0.23
- SCNI 0.15
- MACD
- LKCO 0.00
- SCNI -0.00
- Stochastic Oscillator
- LKCO 2.88
- SCNI 42.86
About LKCO Luokung Technology Corp
Luokung Technology Corp is a spatial-temporal intelligent big data services company, as well as a provider of LBS for various industries in China. It has established city-level and industry-level holographic spatial-temporal digital twin systems and actively serves industries including smart transportation (autonomous driving, smart highway and vehicle-road collaboration), natural resource asset management (carbon neutral and environmental protection remote sensing data service), and LBS smart industry applications (mobile Internet LBS, smart travel, smart logistics, new infrastructure, smart cities, emergency rescue, among others).
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.